Silo Pharma, Inc. (SILO)
2.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
2.15
0.00 (0.00%)
After-Hours: 20:00
Silo Pharma Total Liabilities (Quarterly) : 1.066M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.066M |
| March 31, 2026 | 1.336M |
| December 31, 2025 | 1.300M |
| September 30, 2025 | 1.376M |
| June 30, 2025 | 1.735M |
| March 31, 2025 | 1.889M |
| December 31, 2024 | 2.378M |
| September 30, 2024 | 1.784M |
| June 30, 2024 | 2.080M |
| March 31, 2024 | 1.649M |
| December 31, 2023 | 1.569M |
| September 30, 2023 | 1.490M |
| June 30, 2023 | 1.950M |
| March 31, 2023 | 1.580M |
| December 31, 2022 | 1.302M |
| September 30, 2022 | 1.196M |
| June 30, 2022 | 1.171M |
| March 31, 2022 | 1.213M |
| December 31, 2021 | 1.428M |
| September 30, 2021 | 1.239M |
| June 30, 2021 | 1.238M |
| March 31, 2021 | 1.273M |
| December 31, 2020 | 0.146M |
| September 30, 2020 | 0.1337M |
| June 30, 2020 | 0.0917M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2656M |
| December 31, 2019 | 0.1167M |
| September 30, 2019 | 0.0878M |
| June 30, 2019 | 0.0326M |
| March 31, 2019 | 0.0582M |
| December 31, 2018 | |
| September 30, 2018 | 0.0287M |
| June 30, 2018 | 0.0451M |
| March 31, 2018 | 0.0723M |
| December 31, 2017 | 0.0383M |
| September 30, 2017 | 0.0304M |
| June 30, 2017 | 0.0206M |
| March 31, 2017 | 0.0902M |
| December 31, 2016 | 0.0531M |
| September 30, 2016 | 0.0493M |
| June 30, 2016 | 0.0726M |
| March 31, 2016 | 0.0373M |
| December 31, 2015 | 0.0908M |
| September 30, 2015 | 0.0008M |
| June 30, 2015 | 0.0001M |
| March 31, 2015 | 0.0014M |
| December 31, 2014 | 0.0026M |
| September 30, 2014 | 0.0062M |
| June 30, 2014 | 0.0029M |
| March 31, 2014 | 0.012M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.952M |
| Shareholders Equity (Quarterly) | 4.886M |
| Current Ratio | 5.361 |